Advances in the regulatory mechanisms of mTOR in necroptosis
Molecular mechanisms of necroptosis A wide range of signals act as an inducer of necroptosis. TNFR1 bound with TNFα promotes the recruitment of TRADD to assembly complex I, which comprises TRAF2, RIPK1, cIAP1/2, and LUBAC. cIAP1/2 and LUBAC catalyze the connection of K63- and M1-linked ubiquitin chains to RIPK1, which provides a platform for the recruitment of TAK1, TAB2/3, and the IKK complex consisting of NEMO, IKKα, and IKKβ. The kinases mentioned above can inhibit the activity of RIPK1 through phosphorylation to counteract the shift from complex I to complex II. In addition, MAPK and NF-κB signaling pathways are activated downstream of the kinases mentioned above to induce survival. NF-κB facilitates the synthesis of cFLIP, which inhibits the activity of caspase 8 (CASP8). Upon blocking NF-κB, TRADD assembles with FADD and CASP8 to form complex IIa, which mediates RIPK1-independent apoptosis. In certain cases, including cIAP1/2 or LUBAC inhibition and CYLD-mediated RIPK1 deubiquitination, RIPK1 is dissociated from complex I to form complex IIb with FADD and CASP8, inducing RIPK1-dependent apoptosis. Inactivating CASP8 is a prerequisite for the detachment of RIPK1 from complex IIb. RIPK1 is supposed to undergo conformational changes through autophosphorylation and interact with RIPK3 through the RHIM domain. Phosphorylated RIPK3 is oligomerized to recruit and activate MLKL, leading to the assembly of the necrosome. The activated MLKL oligomer is translocated to the cell membrane, mediating membrane perforation and necroptosis. In addition to TNFα, the connection of FasL to Fas and TRAIL to TRAILR transfers a pro-necroptotic signal. DISC comprises FADD and CASP8 to induce apoptosis. Under cIAP1/2 inhibition, DISC associates with RIPK1 to form complex IIb, which can transfer to the necrosome with CASP8 inhibition. TLR3/4 recruits RHIM-containing TRIF in the intracellular domain after dsRNA and LPS are identified, to directly activate the RIPK3/MLKL pathway and thereby trigger necroptosis. ZBP connected to Z-DNA interacts with RIPK3 through the RHIM domain to stimulate downstream MLKL and induce necroptosis. TNF-α, tumor necrosis factor-α; TNFR1, tumor necrosis factor receptor; TRADD, TNF receptor type 1 associated death domain; TRAF2, TNF receptor associated factor 2; RIPK, receptor-interacting serine-threonine kinase; LUBAC, linear ubiquitin chain assembly complex; cIAP1/2, cellular inhibitors of apoptosis 1/2; TAK1, transforming growth factor-β-activated kinase1; TAB2, TAK1-binding protein2; IKKα/β, IKK complex constituted of IκB kinase α/β; NEMO, NF-κB essential modulator; MAPK, mitogen-activated protein kinase; CYLD, Cylindromatosis; OTULIN, OTU deubiquitinase with linear linkage specificity; cFLIP, cellular FLICE-like inhibitory protein; CASP, caspase; FADD, Fas associated death domain; DISC, death-inducing signaling complex; MLKL, mixed lineage kinase domain-like protein; TLR, toll-like receptor; TRIF, Toll/IL-1 receptor domain-containing adaptor protein inducing interferon-β; dsRNA, double-stranded RNA; LPS, lipopolysaccharide; TRAIL, TNF-related apoptosis-inducing ligand.